Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes.

MLA

Khan, Muhammad Shahzeb, et al. “Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes.” JACC. Heart Failure, vol. 10, no. 3, Mar. 2022, pp. 198–210. EBSCOhost, https://doi.org/10.1016/j.jchf.2021.11.001.

APA

Khan, M. S., Solomon, N., DeVore, A. D., Sharma, A., Felker, G. M., Hernandez, A. F., Heidenreich, P. A., Matsouaka, R. A., Green, J. B., Butler, J., Yancy, C. W., Peterson, P. N., Fonarow, G. C., & Greene, S. J. (2022). Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes. JACC. Heart Failure, 10(3), 198–210. https://doi.org/10.1016/j.jchf.2021.11.001

Chicago

Khan, Muhammad Shahzeb, Nicole Solomon, Adam D DeVore, Abhinav Sharma, G Michael Felker, Adrian F Hernandez, Paul A Heidenreich, et al. 2022. “Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes.” JACC. Heart Failure 10 (3): 198–210. doi:10.1016/j.jchf.2021.11.001.